To support the idea that enhancing SHP-1 expression in VSMCs can decrease intimal hyperplasia in insulin resistance and type 2 diabetes, we generated transgenic mice overexpressing SHP-1 specifically in VSMCs (Fig. 3a). The gene discussed is PTPN6; the disease is type 2 diabetes mellitus.